Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTSC Study
NCT03216395Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2018
- Primary completion
- Jan 2021
- Countries
- 3
01
Overview
Randomised, open-label trial in Gastrointestinal Bleeding (GIB) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Bleeding free probability in 30 days after randomization. Started Jan 2018; status: completed.
02
Conditions
Gastrointestinal Bleeding (GIB)
Beyond the preview
Go deeper on NCT03216395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03216395.